Therapeutic implications of synonymous gene recoding: insights into mechanisms controlling protein biogenesis and activity.
Saved in:
| Title: | Therapeutic implications of synonymous gene recoding: insights into mechanisms controlling protein biogenesis and activity. |
|---|---|
| Authors: | Lin BC; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Jankowska KI; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Katneni UK; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Amarasinghe R; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Padhiar N; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Hamasaki-Katagiri N; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Wu WW; Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Zhu H; Cell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, 226-8503, Japan., Taguchi H; Cell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, 226-8503, Japan., Ghosh A; Center for Gene Regulation in Health and Disease and the Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, 44115, United States., Holcomb DD; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Phue JN; Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Fumagalli SE; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Freedberg DI; Laboratory of Bacterial Polysaccharides, Division of Bacterial, Parasitic, and Allergenic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Kimchi O; Center for the Physics of Biological Function, Princeton University, Princeton, NJ, 08544, United States., Shen RF; Facility for Biotechnology Resources, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Komar AA; Center for Gene Regulation in Health and Disease and the Department of Biological, Geological and Environmental Sciences, Cleveland State University, Cleveland, OH, 44115, United States., Sauna ZE; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States., Kimchi-Sarfaty C; Division of Hemostasis, Office of Therapeutic Products, Center for Biologics Evaluation and Research, US FDA, Silver Spring, MD, 20993, United States. |
| Source: | Protein & cell [Protein Cell] 2025 Oct 31; Vol. 16 (10), pp. 905-910. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: Germany NLM ID: 101532368 Publication Model: Print Cited Medium: Internet ISSN: 1674-8018 (Electronic) Linking ISSN: 1674800X NLM ISO Abbreviation: Protein Cell Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1674-8018 |
|---|---|
| DOI: | 10.1093/procel/pwaf028 |
